🍪 CompoundTalk uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsInternationalHas anyone dealt with german private insurance (pkv) vs statutory (gkv)? Page 5

Has anyone dealt with german private insurance (pkv) vs statutory (gkv)?

B12Beth Wed, Apr 16, 2025 at 1:17 AM 36 replies 1,942 viewsPage 5 of 8
sophie_paris
Member
212
890
Nov 2024
Paris, FR
May 20, 2025 at 10:08 PM#21
anders_CPH said:
If you are comparing against somebody else’s result, check that you are comparing the same measurement taken the same way.

Genuinely useful, thank you. I had the facts and not the framework. Printing the relevant bit and taking it with me.

Last edited: May 21, 2025 at 3:08 AM
43 18SallyK_inj, CryptoCarl, MariaRD and 40 others
Reply Quote Save Share Report
Dr.NateNeph
VIP Member
2,987
16,234
Dec 2023
Houston, TX
Jun 3, 2025 at 2:47 PM#22

Adding the clinical framing, because it changes how the question reads. The honest answer is that the effect is real, the magnitude is contested, and the individual variation is larger than either. Those three things can all be true at once, and most arguments here are two people holding different parts of that.

42 17NauseaFreeNow, SteveThurs, B12Beth and 39 others
Reply Quote Save Share Report
JennaRN
Senior Member
1,987
8,923
Mar 2024
Colorado
Online
Jun 17, 2025 at 7:18 AM#23
Dr.NateNeph said:
The honest answer is that the effect is real, the magnitude is contested, and the individual variation is larger than either.

Same pattern here, and in the same order. The detail I would add is minor and it is already implied above.

41 16BiostatsBrad, PeptideSynthNJ, Dr.KarenChen and 38 others
Reply Quote Save Share Report

Sigma-Aldrich — Research-Grade Standards

Certified reference materials, analytical reagents, and research-grade standards for peptide verification. Trusted by laboratories worldwide.

Shop Reference Standards
CarlaRPh_TPA
Senior Member
1,890
8,234
Jan 2024
Tampa, FL
Jun 30, 2025 at 11:41 PM#24
Dr.NateNeph said:
The honest answer is that the effect is real, the magnitude is contested, and the individual variation is larger than either.

There is a second half to this that has not been said yet. It is worth asking what the claim would look like if it were false. If nothing would look different, it is not a claim about the world and no amount of discussion will settle it.

Last edited: Jul 1, 2025 at 3:41 AM
40 15labquiet_amy, emily_PDX, Dr.SleepRoch and 37 others
Reply Quote Save Share Report
lisa_labSD
Member
278
1,234
Oct 2024
San Diego, CA
Jul 14, 2025 at 3:56 PM#25

One concrete data point for the thread. Give anything pharmacological four weeks before you judge it, and give anything measured weekly a four-point rolling average before you call it a trend.

39 14cory_ATX, lori_vegas, Dr.PulmRoch and 36 others
Reply Quote Save Share Report

Similar Threads

EU EMA compounding guidance — 2026 regulatory update9 replies
UK NHS GLP-1 prescribing — NICE TA875 and access guide7 replies
Australian TGA scheduling changes — peptide access 20268 replies
Canadian GLP-1 coverage — provincial formulary comparison6 replies
Purchasing GLP-1 in Mexico — legality, quality, and safety concerns6 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register